The coronavirus (COVID-19) outbreak has revealed both the strengths and weaknesses of China’s healthcare system, according to an article from China Briefing.
On the one hand, the Chinese government was able to massively increase the country’s short-term care capacity, providing emergency hospital beds and conducting widespread testing. On the other hand, the outbreak exposed wide disparities in the quality of care between hospitals across regions.
COVID-19 and the lessons learned from managing the outbreak could profoundly shape the direction of China’s healthcare market, which had been projected to be worth RMB 16 trillion (US$2.3 trillion) by 2030.
What will happen to China’s healthcare sector, once the coronavirus is overcome and what opportunities it realistically presents foreign investors?
Follow the link to read more.